Sterling R - Search Results

1

PNPLA3 Gene Polymorphisms in HCV/HIV-Coinfected Individuals.

Sherman KE, Rouster SD, Kang M, Umbleja T, Sterling R, Butt AA; ACTG 5294 BIRTH Study Team. Sherman KE, et al. Among authors: sterling r. Dig Dis Sci. 2018 Nov;63(11):2969-2974. doi: 10.1007/s10620-018-5278-y. Epub 2018 Sep 14. Dig Dis Sci. 2018. PMID: 30218427 Free PMC article. Clinical Trial.

2

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.

Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, S Sulkowski M, Torriani FJ, Dieterich DT, Thomas DL, Messinger D, Nelson M; APRICOT Clinical Investigators. Sterling RK, et al. Hepatology. 2006 Jun;43(6):1317-25. doi: 10.1002/hep.21178. Hepatology. 2006. PMID: 16729309

3

Hepatitis C and HIV.

Smith JO, Sterling RK. Smith JO, et al. Curr Gastroenterol Rep. 2007 Mar;9(1):83-90. doi: 10.1007/s11894-008-0025-8. Curr Gastroenterol Rep. 2007. PMID: 17335682 Review.

4

The prevalence and risk factors for abnormal liver enzymes in HIV-positive patients without hepatitis B or C coinfections.

Sterling RK, Chiu S, Snider K, Nixon D. Sterling RK, et al. Dig Dis Sci. 2008 May;53(5):1375-82. doi: 10.1007/s10620-007-9999-6. Epub 2007 Oct 16. Dig Dis Sci. 2008. PMID: 17939038 Free PMC article.

5

Response to hepatitis A and B vaccine alone or in combination in patients with chronic hepatitis C virus and advanced fibrosis.

Kramer ES, Hofmann C, Smith PG, Shiffman ML, Sterling RK. Kramer ES, et al. Dig Dis Sci. 2009 Sep;54(9):2016-25. doi: 10.1007/s10620-009-0867-4. Epub 2009 Jun 11. Dig Dis Sci. 2009. PMID: 19517231

6

Sterling RK, Wegelin JA, Smith PG, Stravitz RT, Luketic VA, Fuchs M, Puri P, Shiffman ML, Contos MA, Mills AS, Sanyal AJ. Sterling RK, et al. Clin Gastroenterol Hepatol. 2010 Dec;8(12):1070-6. doi: 10.1016/j.cgh.2010.08.004. Epub 2010 Aug 20. Clin Gastroenterol Hepatol. 2010. PMID: 20728569 Free PMC article.

7

Comparison of FIB-4 and APRI in HIV-HCV coinfected patients with normal and elevated ALT.

Shah AG, Smith PG, Sterling RK. Shah AG, et al. Dig Dis Sci. 2011 Oct;56(10):3038-44. doi: 10.1007/s10620-011-1710-2. Epub 2011 Apr 28. Dig Dis Sci. 2011. PMID: 21526398

8

Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial.

Sulkowski M, Pol S, Mallolas J, Fainboim H, Cooper C, Slim J, Rivero A, Mak C, Thompson S, Howe AY, Wenning L, Sklar P, Wahl J, Greaves W; P05411 study investigators. Sulkowski M, et al. Lancet Infect Dis. 2013 Jul;13(7):597-605. doi: 10.1016/S1473-3099(13)70149-X. Epub 2013 Jun 12. Lancet Infect Dis. 2013. PMID: 23768747 Clinical Trial.

9

Modulation of HCV replication after combination antiretroviral therapy in HCV/HIV co-infected patients.

Sherman KE, Guedj J, Shata MT, Blackard JT, Rouster SD, Castro M, Feinberg J, Sterling RK, Goodman Z, Aronow BJ, Perelson AS. Sherman KE, et al. Sci Transl Med. 2014 Jul 23;6(246):246ra98. doi: 10.1126/scitranslmed.3008195. Sci Transl Med. 2014. PMID: 25101888 Free PMC article.

10

Utility of evaluating HCV in an uninsured population.

Donepudi I, Paredes A, Hubbard S, Awad C, Sterling RK. Donepudi I, et al. Dig Dis Sci. 2015 Apr;60(4):1092-7. doi: 10.1007/s10620-014-3416-8. Epub 2014 Nov 5. Dig Dis Sci. 2015. PMID: 25371153

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

584 results

Search Page